Form 4: GRAIL Director Acquires Stock Units in Lieu of Cash

GRAIL Director William J. Chase acquired 213 deferred stock units, valued at $97.44 per share, as compensation for his service, demonstrating alignment with shareholder interests.

Summary

• William J. Chase, a Director of GRAIL, Inc., acquired 213 deferred stock units.
• These units were granted on January 15, 2026, in lieu of $20,794.52 in cash fees for his director service.
• The price per share used for the grant was $97.44, which was the closing price of GRAIL's common stock on the transaction date.
• The awards vested immediately upon grant.
• Following this transaction, Mr. Chase beneficially owns 36,803 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the director's decision to take equity instead of cash compensation demonstrates alignment with shareholder interests and confidence in the company's future value. However, it is a routine insider transaction and not indicative of significant operational or financial news.

Positives

• Director William J. Chase elected to receive equity (deferred stock units) instead of cash compensation, aligning his interests with those of shareholders.
• The immediate vesting of the awards indicates a direct and immediate stake in the company's performance.

Negatives

• No direct negatives are apparent from this routine insider transaction filing.

Risks

• The value of the acquired deferred stock units is subject to the market fluctuations of GRAIL, Inc.'s common stock.
• General market risks associated with holding equity securities.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• This filing does not contain direct quotes or paraphrased statements from company management, as it is a statutory report of an insider transaction.

Industry Context

It is common practice for directors of publicly traded companies to receive a portion of their compensation in the form of equity, such as stock options or restricted stock units, to align their interests with those of shareholders. This transaction reflects a standard approach to director compensation within the biotechnology or healthcare industry, where equity incentives are often used to attract and retain talent and foster long-term commitment.

Comparison to Industry Standards

• The practice of compensating directors with equity, specifically deferred stock units, is a widely accepted corporate governance standard across various industries, including biotechnology and diagnostics.
• Companies like Illumina (ILMN), Exact Sciences (EXAS), and Guardant Health (GH) often utilize similar equity-based compensation structures for their non-employee directors to promote alignment with shareholder value.
• The immediate vesting of these units is also a common feature for director compensation, ensuring directors have an immediate stake in the company's performance, unlike employee grants which often have multi-year vesting schedules.

Corporate Governance

Related Party Transactions

• The acquisition of deferred stock units by Director William J. Chase in lieu of cash fees constitutes a related party transaction, as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The decision by a director to receive equity compensation instead of cash can be viewed positively by shareholders, as it aligns the director's financial interests directly with the company's stock performance and long-term value creation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Next Steps

• This filing does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Keywords

GRAIL Inc, GRAL, Form 4, Insider Transaction, William J. Chase, Director Compensation, Deferred Stock Units, Equity Compensation, Stock Acquisition, Corporate Governance